Search Within

Michael Morris

  1. "Biostatistics Service"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (30)
  3. Review (2)
Groups
  1. Biostatistics Service (87)
  2. Department of Medicine (87)
  3. Epidemiology and Biostatistics (87)
  4. Genitourinary Oncology Service (87)
  5. Solid Tumor Oncology Division (87)
  6. Radiology, Department of (41)

More Groups

People
  1. Glenn Heller (54)
  2. Howard Scher (52)
  3. Steven Larson (29)
  4. Susan Slovin (22)
  5. Mithat Gonen (19)
  6. Dana Rathkopf (15)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (9)
  5. 2021 (7)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (9)
  3. Journal of Nuclear Medicine (6)
  4. Cancer (3)
  5. Clinical Genitourinary Cancer (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (10)
  3. Society of Nuclear Medicine (6)
  4. Elsevier Science, Inc. (5)
  5. Oxford University Press (5)
  6. Elsevier BV (4)

More Publishers

Results (87)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Morris, M. J.; Fox, J. J.; Danila, D. C.; Slovin, S. F.; Hager, J. H.; Rix, P. J.; Chow-Maneval, E.; Chen, I.; Gonen, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Repetitively dosed docetaxel and 153samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Journal Article

    Autio, K. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Stephenson, R. D.; Slovin, S. F.; Rathkopf, D. E.; Hong, C.; Heller, G.; Scher, H. I.; Larson, S. M.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Validation and clinical utility of prostate cancer biomarkers
    Journal Article

    Scher, H. I.; Morris, M. J.; Larson, S.; Heller, G.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy
    Journal Article

    Gourtsoyianni, S.; Hwang, S.; Panicek, D. M.; Zheng, J.; Moskowitz, C.; Scher, H.; Morris, M.; Hricak, H.
    British Journal of Radiology (2012)

    Fulltext@MSK | Save
  • A phase I trial of docetaxel and pulse-dose 17-allylamino-17- demethoxygeldanamycin in adult patients with solid tumors
    Journal Article

    Iyer, G.; Morris, M. J.; Rathkopf, D.; Slovin, S. F.; Steers, M.; Larson, S. M.; Schwartz, L. H.; Curley, T.; Delacruz, A.; Ye, Q.; more...
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • Bone scan index: A quantitative treatment response biomarker for castration-resistant metastatic prostate cancer
    Journal Article

    Dennis, E. R.; Jia, X.; Mezheritskiy, I. S.; Stephenson, R. D.; Schoder, H.; Fox, J. J.; Heller, G.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT
    Journal Article

    Fox, J. J.; Autran-Blanc, E.; Morris, M. J.; Gavane, S.; Nehmeh, S.; Van Nuffel, A.; Gonen, M.; Schoder, H.; Humm, J. L.; Scher, H. I.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • End points and outcomes in castration-resistant prostate cancer: From clinical trials to clinical practice
    Journal Article

    Scher, H. I.; Morris, M. J.; Basch, E.; Heller, G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save